By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
  • Podcast & Media
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • GMJ Briefs
  • Read the Journal →
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
  • Podcast & Media
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • GMJ Briefs
  • Read the Journal →
Follow US
GMJ News > Clinical Medicine > #17 | WHO: Global Population Requiring Trachoma Interventions Falls Below 100 Million

#17 | WHO: Global Population Requiring Trachoma Interventions Falls Below 100 Million

GMJ
Last updated: 03/04/2026 21:07
By
GMJ News Desk
Share
2 Min Read
SHARE
GMJ Podcast · Episode 17
March 4, 2026 16m Prof. Giorgi Pkhakadze
Clinical MedicineGlobal HealthHealth PolicyJournal NewsPublic Health
Listen to this episode
Spotify Apple Podcasts YouTube Amazon Music Castbox Goodpods Pocket Casts Download

Episode Summary

The World Health Organization reports a historic milestone in global eye health: the population requiring trachoma interventions has fallen below 100 million for the first time since monitoring began. With the prevalence declining to 97.1 million in 2025—a 94% reduction from 1.5 billion at-risk individuals in 2002—this episode examines how coordinated implementation of the SAFE strategy has transformed trachoma elimination efforts worldwide. Trachoma, caused by Chlamydia trachomatis, remains the leading infectious cause of blindness globally, yet sustained public health interventions continue to drive remarkable progress toward disease elimination.

Key Topics Discussed

  • Trachoma epidemiology and the burden of infectious blindness in endemic regions
  • The WHO SAFE strategy: Surgery, Antibiotics, Facial cleanliness, and Environmental improvements
  • Global partnerships between national health systems, NGOs, and international organizations
  • Water, sanitation, and hygiene (WASH) interventions in trachoma prevention
  • Progress toward the 2030 trachoma elimination goal and remaining challenges
  • Public health policy frameworks supporting disease elimination programs

Key Takeaways

  • The 94% reduction in trachoma burden demonstrates the effectiveness of integrated, multisectoral public health approaches over two decades of sustained effort
  • Coordinated implementation of the evidence-based SAFE strategy has successfully reduced transmission and prevented blindness across diverse epidemiological settings
  • Nearly 100 million people still require interventions, highlighting the critical need for continued investment and global cooperation to achieve complete disease elimination
  • Improvements in water and sanitation infrastructure directly correlate with reduced trachoma transmission and improved eye health outcomes
  • Successful trachoma elimination requires sustained partnerships between governments, civil society, and international health organizations

About This Episode

This episode addresses a pivotal achievement in global health policy and clinical medicine with implications for resource allocation, health equity, and disease prevention strategies. Trachoma elimination represents a cornerstone of the WHO's vision for universal eye health and demonstrates how systematic public health interventions can eliminate infectious causes of preventable blindness. For healthcare professionals, policymakers, and global health advocates, understanding trachoma's trajectory offers valuable insights into scaling successful elimination strategies across endemic regions, including considerations for countries in the Caucasus and Eastern Europe. The milestone underscores the importance of continued surveillance, investment in community-based interventions, and cross-sector collaboration to realize the 2030 elimination goal.

Full Description

In this episode of the GMJ Podcast — the official podcast of the Georgian Medical Journal, we examine a major milestone in global eye health reported by the World Health Organization (WHO).

For the first time since global monitoring began, the number of people requiring interventions against trachoma, the world’s leading infectious cause of blindness, has fallen below 100 million. According to WHO data, the population needing interventions declined to 97.1 million in 2025, compared with 1.5 billion people estimated to be at risk in 2002. This represents a remarkable 94% reduction over the past two decades.

Trachoma is a bacterial infection caused by Chlamydia trachomatis. Repeated infections can cause scarring of the eyelid and eventually lead to irreversible blindness if left untreated.

The progress achieved globally reflects decades of coordinated efforts by national health systems, international partners and community health programmes implementing the WHO-endorsed SAFE strategy:

• Surgery to treat trachomatous trichiasis
• Antibiotics to eliminate infection
• Facial cleanliness to reduce transmission
• Environmental improvements such as better water and sanitation

This coordinated strategy has significantly reduced transmission across many endemic regions and helped numerous countries eliminate trachoma as a public health problem.

The episode explores several key public health themes:

• Trachoma as the leading infectious cause of blindness
• The global success of the SAFE elimination strategy
• Partnerships between governments, NGOs and international organizations
• The importance of sanitation, hygiene and community health interventions
• The global goal of eliminating trachoma as a public health problem by 2030

Although major progress has been achieved, nearly 100 million people still require interventions, meaning continued investment and global cooperation will be essential to eliminate the disease completely.

Original WHO source discussed in this episode:
https://www.who.int/news/item/06-01-2026-global-population-requiring-interventions-against-trachoma-falls-below-100-million-for-the-first-time

The GMJ Podcast accompanies peer-reviewed publications and global health policy discussions published in the Georgian Medical Journal.

Journal website:
https://gmj.ge/index.php/pub/index

#გიორგიფხაკაძე #drpkhakadze #sheniekimi

Show more ↓
Post on X LinkedIn Facebook Telegram Email Copy link
Cite this episode: Prof. Giorgi Pkhakadze. "#17 | WHO: Global Population Requiring Trachoma Interventions Falls Below 100 Million." The Georgian Medical Journal Podcast, Episode 17, March 4, 2026. https://news.gmj.ge/podcast-media/17-who-global-population-requiring-trachoma-interventions-falls-below-100-millio/
Related on GMJ News
Daily Multivitamins May Slow Biological Aging and Cognitive Decline, Major Study Finds UK's Healthy Life Expectancy Falls: A Population Health Crisis Emerges Bacterial STIs Hit Decade-High in Europe as Gonorrhea and Syphilis Cases Surge New antibiotic combinations show promise against resistant urinary tract infections Japanese Researcher Develops Novel Malaria Vaccine Strategy Against Transmission-Blocking Targets

Submit Your Paper to GMJ

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.

Submit Your Paper →
More Episodes

How Georgian Medical Journal Entered the Swiss Academic System (ETH Library)

Podcast · 4m · May 2026

NAD⁺ Injections and “NAD Boosters”

Video · Apr 2026

GMJ Video Series | Rare Case: Lung Cancer & Tuberculosis Coexistence

Video · Apr 2026

The Blueprint of a Medical Journal: Designing an Open-Access Scientific Platform

Podcast · 19m · Apr 2026

← #16 | WHO Prequalifies New Oral Polio Vaccine…
All Episodes
#18 | WHO Updates HIV Clinical Management Guidelines… →
Share This Article
Facebook LinkedIn Bluesky Copy Link Print

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
US Travel Restrictions on Ebola-Exposed Regions Draw Human Rights Concerns

US travel restrictions on travelers from Ebola-affected regions in Central Africa are…

Healthcare Systems Must Prioritize Human Connection to Combat Employee Burnout Crisis

Healthcare workers face unprecedented burnout rates of 76%, driven by digital systems…

WHO Declares Ebola Outbreak in DRC and Uganda a Global Health Emergency

WHO declares Ebola outbreak in DRC and Uganda a global health emergency…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

#32 | GMJ Podcast | Launch of the Georgian Medical Journal — A New International Platform for Medical Science

By
GMJ News Desk

#48 | GMJ Podcast | Launching the Georgian Medical Journal — Transparency, Editorial Standards, and Open-Access Vision

By
GMJ News Desk

#34 | GMJ Podcast | Palliative Care in Georgia — Health System Gaps and Policy Implications

By
GMJ News Desk

The Architecture of Migration Health: Inside the GMJ Knowledge Hub | Georgian Medical Journal

By
GMJ News Desk
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

[mc4wp_form]

Join Community
Made by ThemeRuby using the Foxiz theme. Powered by WordPress
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up